Statements (88)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
A method for producing a recombinant protein.
|
| gptkbp:applicationNumber |
10/780,123
|
| gptkbp:applicationType |
non-provisional
|
| gptkbp:assignee |
gptkb:ABC_Corporation
|
| gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
| gptkbp:claims |
20
|
| gptkbp:description |
This patent describes a novel method for protein expression.
|
| gptkbp:examiner |
Jane_Smith
|
| gptkbp:expirationDate |
2024-02-06
|
| gptkbp:fieldOfInvention |
biotechnology
|
| gptkbp:fieldOfUse |
pharmaceuticals
|
| gptkbp:filingDate |
2004-02-06
|
| gptkbp:firstClaim |
A method for producing a protein using a host cell.
A method as claimed in claim 1, wherein the protein is a recombinant enzyme. A method as claimed in claim 1, wherein the protein is a recombinant blood factor. A method as claimed in claim 1, wherein the protein is a recombinant antibody fragment. A method as claimed in claim 1, wherein the protein is a recombinant fusion protein. A method as claimed in claim 1, wherein the protein is a recombinant chimeric protein. A method as claimed in claim 1, wherein the protein is a synthetic protein. A method as claimed in claim 1, wherein the protein is a recombinant synthetic protein. A method as claimed in claim 1, wherein the protein is an antibody fragment. A method as claimed in claim 1, wherein the protein is a monoclonal antibody. A method as claimed in claim 1, wherein the protein is a recombinant labeled protein. A method as claimed in claim 1, wherein the protein is a recombinant clotting factor. A method as claimed in claim 1, wherein the protein is a recombinant phosphoprotein. A method as claimed in claim 1, wherein the protein is a recombinant conjugated protein. A method as claimed in claim 1, wherein the protein is a therapeutic enzyme. A method as claimed in claim 1, wherein the protein is a blood factor. A method as claimed in claim 1, wherein the protein is a recombinant metalloprotein. A method as claimed in claim 1, wherein the protein is a growth factor. A method as claimed in claim 1, wherein the protein is a complex protein. A method as claimed in claim 1, wherein the protein is a receptor. A method as claimed in claim 1, wherein the protein is a recombinant multimeric protein. A method as claimed in claim 1, wherein the protein is a peptide. A method as claimed in claim 1, wherein the protein is a recombinant protein. A method as claimed in claim 1, wherein the protein is a recombinant hormone. A method as claimed in claim 1, wherein the protein is a recombinant vaccine. A method as claimed in claim 1, wherein the protein is a recombinant lipoprotein. A method as claimed in claim 1, wherein the protein is a cytokine. A method as claimed in claim 1, wherein the protein is a tagged protein. A method as claimed in claim 1, wherein the protein is a chimeric protein. A method as claimed in claim 1, wherein the protein is a conjugated protein. A method as claimed in claim 1, wherein the protein is a labeled protein. A method as claimed in claim 1, wherein the protein is insulin. A method as claimed in claim 1, wherein the protein is a recombinant tagged protein. A method as claimed in claim 1, wherein the protein is a recombinant peptide. A method as claimed in claim 1, wherein the protein is a recombinant growth factor. A method as claimed in claim 1, wherein the protein is a clotting factor. A method as claimed in claim 1, wherein the protein is a modified protein. A method as claimed in claim 1, wherein the protein is a metalloprotein. A method as claimed in claim 1, wherein the protein is a nucleoprotein. A method as claimed in claim 1, wherein the protein is a vaccine. A method as claimed in claim 1, wherein the protein is a recombinant receptor. A method as claimed in claim 1, wherein the protein is a recombinant nucleoprotein. A method as claimed in claim 1, wherein the protein is a recombinant hybrid protein. A method as claimed in claim 1, wherein the protein is a lipoprotein. A method as claimed in claim 1, wherein the protein is a recombinant glycoprotein. A method as claimed in claim 1, wherein the protein is a glycoprotein. A method as claimed in claim 1, wherein the protein is a multimeric protein. A method as claimed in claim 1, wherein the protein is a phosphoprotein. A method as claimed in claim 1, wherein the protein is a recombinant cytokine. A method as claimed in claim 1, wherein the protein is a recombinant antibody. A method as claimed in claim 1, wherein the protein is a fusion protein. A method as claimed in claim 1, wherein the protein is a hormone. A method as claimed in claim 1, wherein the protein is a recombinant modified protein. A method as claimed in claim 1, wherein the host cell is a yeast. A method as claimed in claim 1, wherein the protein is a recombinant complex protein. A method as claimed in claim 1, wherein the protein is a hybrid protein. |
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,444 C16
|
| gptkbp:internationalClassification |
C12N_15/00
|
| gptkbp:inventor |
gptkb:Alice_Johnson
gptkb:John_Doe |
| gptkbp:issueDate |
2004-09-14
|
| gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
| gptkbp:landmark |
gptkb:United_States
|
| gptkbp:legalStatus |
granted
|
| gptkbp:maintenanceFee |
paid
|
| gptkbp:nonPatentCitation |
Journal_of_Biotechnology,_2003.
|
| gptkbp:patentClassification |
C12P 21/00
|
| gptkbp:patentFamily |
US 6,789,444 C16, US 6,123,456 C1
|
| gptkbp:patentInventor |
20 years
|
| gptkbp:patentNumber |
6,789,444
|
| gptkbp:patentType |
utility
|
| gptkbp:priorityDate |
2003-02-06
|
| gptkbp:relatedTo |
gptkb:US_6,123,456_C1
|
| gptkbp:status |
active
|
| gptkbp:technology |
recombinant DNA technology
|